Metraipolis › archive › dc_7d47379358bc

Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study - Study… — Europe PMC PMID:42568775

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42568775
DOI
10.1016/j.ctro.2026.101245
License (as archived)
solo-consultazione
Archived
2026-10-17T19:25:23.673Z
SHA-256 of the archived text
ce9eaa05f3bfc04159e6d03e625f2fc78263d16386dff997400ec66018e9c55a
Stable URL of this page
https://metraipolis.com/documento/dc_7d47379358bc

How to cite

Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study - Study… — Europe PMC PMID:42568775 — Europe PMC (en), https://europepmc.org/article/MED/42568775 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7d47379358bc (Metraipolis archive dc_7d47379358bc, sha256 ce9eaa05f3bfc04159e6d03e625f2fc78263d16386dff997400ec66018e9c55a)
BibTeX
@misc{dc7d47379358bc,
  title = {Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study - Study… — Europe PMC PMID:42568775},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42568775},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7d47379358bc; sha256 ce9eaa05f3bfc04159e6d03e625f2fc78263d16386dff997400ec66018e9c55a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42568775. Agents can read the archived copy with the MCP tool read_document.